MGIA
ADCT icon

Moneta Group Investment Advisors’s ADC Therapeutics ADCT Stock Holding History

Moneta Group Investment Advisors’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,496
Closed -$32.4K – 608
2023
Q4 		$32.4K Hold
19,496
– – ﹤0.01% 558
2023
Q3 		$17.5K Hold
19,496
– – ﹤0.01% 522
2023
Q2 		$41.9K Hold
19,496
– – ﹤0.01% 534
2023
Q1 		$38K Hold
19,496
– – ﹤0.01% 528
2022
Q4 		$74.9K Sell
19,496
-6
-0% -$24 ﹤0.01% 442
2022
Q3 		$94K Buy
19,502
+5
+0% +$36 ﹤0.01% 415
2022
Q2 		$155K Buy
19,497
+28
+0.1% +$265 0.01% 445
2022
Q1 		$286K Sell
19,469
-36
-0.2% -$571 0.01% 366
2021
Q4 		$394K Sell
19,505
-9
-0% -$217 0.02% 333
2021
Q3 		$530K Buy
19,514
+7
+0% +$179 0.02% 271
2021
Q2 		$475K Buy
19,507
+7
+0% +$162 0.02% 290
2021
Q1 		$476K Buy
+19,500
New +$565K 0.03% 267

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCG
Vantage Consulting Group Virginia Beach, Virginia $19.7M AUM 280.87% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Moneta Group Investment Advisors's ADCT Position: Q1 2024 in Review

Moneta Group Investment Advisors sold out of ADC Therapeutics (ADCT) in Q1 2024, closing a stake of 19,496 shares — an estimated $32.4K sold.

Moneta Group Investment Advisors first reported a position in ADCT in Q1 2021 and held it in 12 quarters. The position peaked at $530K in Q3 2021. 36 funds tracked by Wall St. Rank hold ADCT as of Q1 2024.

  • Moneta Group Investment Advisors reported no remaining ADC Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Moneta Group Investment Advisors sold 19,496 ADC Therapeutics shares in Q1 2024, an estimated $32.4K.
  • Moneta Group Investment Advisors first reported a position in ADC Therapeutics in Q1 2021 and held it in 12 quarters.
  • Moneta Group Investment Advisors's ADC Therapeutics position peaked at $530K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2024.

Based on Moneta Group Investment Advisors's 13F filing for Q1 2024, filed 13 Aug 2024.